The powder form will be more easily administered to pediatric patients, AbbVie says.
Joe Hannan
Advertisement
Articles by Joe Hannan
Physicians debated whether they would prescribe the new MS drug to a patient.
An overview of the newest treatment options for the disease.
Physicians received an overview of the scope and severity of the disease.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Atacicept and Upstream Immune Targeting in IgAN With Richard Lafayette, MD
2
Culprits in Perioperative Allergy, With Kimberly Blumenthal, MD
3
Enlicitide’s FDA Approval for LDL-C Reduction and the CORALreef Outcomes Trial
4
Retatrutide Meets Phase 3 Weight-Loss Endpoints in 2 Obesity Trials
5